10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 272 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,250 | -83.1% | 5,000 | -77.2% | 0.00% | -82.4% |
| Q2 2023 | $1,222,952 | -2.6% | 21,901 | -2.7% | 0.02% | -5.6% |
| Q1 2023 | $1,255,331 | +74.8% | 22,501 | +14.2% | 0.02% | +63.6% |
| Q4 2022 | $718,159 | +28.0% | 19,708 | 0.0% | 0.01% | +22.2% |
| Q3 2022 | $561,000 | -36.8% | 19,708 | +0.5% | 0.01% | -35.7% |
| Q2 2022 | $888,000 | -31.4% | 19,608 | +15.2% | 0.01% | -17.6% |
| Q1 2022 | $1,295,000 | -42.5% | 17,020 | +12.5% | 0.02% | -39.3% |
| Q4 2021 | $2,253,000 | +10.8% | 15,126 | +8.3% | 0.03% | +3.7% |
| Q3 2021 | $2,033,000 | -25.1% | 13,963 | +0.7% | 0.03% | -22.9% |
| Q2 2021 | $2,715,000 | +35.1% | 13,863 | +24.9% | 0.04% | +25.0% |
| Q1 2021 | $2,009,000 | +372.7% | 11,100 | +270.0% | 0.03% | +366.7% |
| Q4 2020 | $425,000 | +36.2% | 3,000 | +20.0% | 0.01% | +20.0% |
| Q3 2020 | $312,000 | +52.2% | 2,500 | +8.7% | 0.01% | +25.0% |
| Q2 2020 | $205,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |